8-K
filed October 14, 2025, 7:59 PM ET
ticker SYRE
CIK 0001636282
other material
confidence medium
sentiment neutral
materiality 0.50
Spyre Therapeutics expects $486.2M cash as of Sept 30, 2025
Spyre Therapeutics, Inc.
- Preliminary unaudited cash, cash equivalents and marketable securities of ~$486.2M as of Sept 30, 2025.
- Full Q3 2025 financial results not yet finalized; subject to completion of closing procedures.
- Company cautions that final amount may differ materially from preliminary estimate.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-25-237904
- form_type
- 8-K
- ticker
- SYRE
- cik
- 0001636282
- company_name
- Spyre Therapeutics, Inc.
- filed_at
- 2025-10-14T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:40.002418+00:00
- generated_at
- 2026-05-17T03:54:28.919567+00:00
- sec_items
- ["2.02"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- medium
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-25-237904
- json_url
- https://secwatch.observer/filing/0001193125-25-237904.json
- markdown_url
- https://secwatch.observer/filing/0001193125-25-237904.md
- text_url
- https://secwatch.observer/filing/0001193125-25-237904.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1636282/000119312525237904/0001193125-25-237904-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1636282/000119312525237904/d85106d8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SF
Stifel's April 2026 operating data: client assets up 17% YoY to $568.9B
STIFEL FINANCIAL CORP
May 28, 2026, 4:15 PM ET
other_material
Items 7.01, 2.02, 9.01
same SEC item: 2.02
same event type: other_material
similar materiality
Filing page
SEC filing
CLIR
ClearSign Q1 cash $7.7M; operational progress with multiple burner orders and DOE testing
ClearSign Technologies Corp
May 21, 2026, 4:30 PM ET
other_material
Items 2.02, 7.01, 9.01
same SEC item: 2.02
same event type: other_material
similar materiality
Filing page
SEC filing
Pacific Coast Oil Trust
Pacific Coast Oil Trust: no May distribution, $13.7M owed to PCEC, dissolution pending litigation
Pacific Coast Oil Trust
May 29, 2026, 4:16 PM ET
other_material
Items 2.02, 9.01
same SEC item: 2.02
same event type: other_material
Filing page
SEC filing
MNRO
Monro initiates strategic alternatives review; Q4 sales down 7.2%, operating loss narrows
MONRO, INC.
May 27, 2026, 7:44 AM ET
other_material
Items 2.02, 7.01, 8.01, 9.01
same SEC item: 2.02
same event type: other_material
Filing page
SEC filing
JTAI
Jet.AI reports $13.5M cash, $5M SpaceX stake, flyExclusive merger vote June 11
Jet.AI Inc.
May 21, 2026, 5:00 PM ET
other_material
Items 2.02, 5.02, 9.01
same SEC item: 2.02
same event type: other_material
Filing page
SEC filing
PMI
Picard Medical Q1 revenue up 85% to $1.2M; reports $1.4M negative equity, NYSE listing notices
Picard Medical, Inc.
May 21, 2026, 4:15 PM ET
other_material
Items 2.02, 3.01, 7.01, 9.01
same SEC item: 2.02
same event type: other_material
Filing page
SEC filing
KFFB
Kentucky First Federal board to consider resuming quarterly dividend at July 28 special meeting
Kentucky First Federal Bancorp
May 29, 2026, 4:02 PM ET
dividend
Items 2.02, 9.01
same SEC item: 2.02
similar materiality
Filing page
SEC filing
NTAP
NetApp reports Q4/FY2026 results (details not in filing) and adds $1B buyback
NetApp, Inc.
May 28, 2026, 4:05 PM ET
earnings
Items 2.02, 8.01, 9.01
same SEC item: 2.02
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.